Effects of Cardiopulmonary Support With a Novel Pediatric Pump-Lung in a 30-Day Ovine Animal Model

Artificial Organs

Volumn 39, Issue 12, 2015, Pages 989-997

  Liu, Yang ^a,b   Sanchez, Pablo G ^a   Wei, Xufeng ^a,b   Watkins, Amelia C ^a   Niu, Shuqiong ^a   Wu, Zhongjun J ^a   Griffith, Bartley P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Artificial pump lung; Cardiopulmonary support; Heart transplantation; Lung transplantation; Pediatric

Indexed keywords

ANIMALS; ARTIFICIAL HEART; BIOCOMPATIBILITY; CHEMICAL ACTIVATION; HEART; HEMOGLOBIN; OXYGEN; PEDIATRICS; PLATELETS; PUMPS;

ANIMAL MODEL; ARTIFICIAL PUMP-LUNG; CARDIOPULMONARY SUPPORT; HAEMOGLOBINS; HEART TRANSPLANTATION; IN-VIVO; LUNG TRANSPLANTATION; PEDIATRIC PUMPS; PERFORMANCE; PLATELET ACTIVATION;

BIOLOGICAL ORGANS;

HEMOGLOBIN; HEPARIN; LACTATE DEHYDROGENASE; ANTICOAGULANT AGENT; BIOLOGICAL MARKER; BIOMATERIAL; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BIOCOMPATIBILITY; BLOOD CLOTTING TIME; BLOOD OXYGEN TENSION; CARDIOPULMONARY SUPPORT; CONTROLLED STUDY; DEVICE SAFETY; EQUIPMENT DESIGN; FLOW RATE; GAS DIFFUSION; HEMOGLOBIN BLOOD LEVEL; IN VIVO STUDY; LIFE SUPPORT EQUIPMENT; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; PUMP LUNG; SHEEP; THROMBOCYTE ACTIVATION; THROMBOSIS; TREATMENT DURATION; ADVERSE EFFECTS; ANIMAL; ANIMAL MODEL; BLOOD; BLOOD CLOTTING; DEVICE FAILURE; DRUG EFFECTS; HEART LUNG MACHINE; METABOLISM; TIME FACTOR;

ANIMALS; ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; BIOMARKERS; BLOOD COAGULATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEART-LUNG MACHINE; HEMOGLOBINS; HEPARIN; L-LACTATE DEHYDROGENASE; MODELS, ANIMAL; OXYGEN; PLATELET ACTIVATION; SHEEP; THROMBOSIS; TIME FACTORS;

EID: 84952864579     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12487     Document Type: Article

References (13)

1. Go AS, Mozaffarian D, Roger VL, etal. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-292.
2. World Health Organization. Pneumonia. Factsheet no. 331. Geneva: World Health Organization, 2013. Available at: http://www.who.int/mediacentre/factsheets/fs331/en/. Accessed March 10, 2014. Updated November 2014.
3. Haines NM, Rycus PT, Zwischenberger JB, Bartlett RH, Undar A. Extracorporeal Life Support Registry Report 2008: neonatal and pediatric cardiac cases. ASAIO J 2009;55:111-116.
4. Iacono A, Groves S, Garcia J, Griffith B. Lung transplantation following 107 days of extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2010;37:969-971.
5. Javidfar J, Brodie D, Iribarne A, etal. Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery. J Thorac Cardiovasc Surg 2012;144:716-721.
6. Lang G, Taghavi S, Aigner C, etal. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation 2012;93:729-736.
7. Baldwin JT, Borovetz HS, Duncan BW, etal. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation 2006;113:147-155.
8. Wu ZJ, Gellman B, Zhang T, Taskin ME, Dasse KA, Griffith BP. Computational fluid dynamics and experimental characterization of the pediatric pump-lung. Cardiovasc Eng Technol 2011;2:276-287.
9. Wu ZJ, Zhang T, Bianchi G, etal. Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Ann Thorac Surg 2012;93:274-281.
10. Wu ZJ, Taskin ME, Zhang T, Fraser KH, Griffith BP. Computational model-based design of a wearable artificial pump-lung for cardiopulmonary/respiratory support. Artif Organs 2012;36:387-399.
11. Kilic A, Nolan TD, Li T, etal. Early in vivo experience with the pediatric Jarvik 2000 heart. ASAIO J 2007;53:374-378.
12. Dierickx PW, De Wachter DS, De Somer F, Van Nooten G, Verdonck PR. Mass transfer characteristics of artificial lungs. ASAIO J 2001;47:628-633.
13. Mah D, Singh TP, Thiagarajan RR, etal. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant 2009;28:1292-1298.